Skeletal Dysplasia Territory Manager – Rare Disease Launch

BridgeBio Pharma is seeking a Skeletal Dysplasia Account Manager to lead the launch of Infigratinib for achondroplasia, bringing clinical acumen and urgency to engage providers and families. The role covers the Southeast Region and involves close partnership with field teams and leadership.

You will drive territory strategy, develop key account relationships with geneticists and pediatric specialists, and advocate for patients and families in a fast-paced biopharma environment.